Venoarterial extracorporeal membrane oxygenation provides cardiorespiratory support to
patients in cardiogenic shock. This comes at the cost of increased left ventricle (LV) afterload …

Despite the rapidly evolving evidence base in modern cardiology, progress in the area of
cardiogenic shock remains slow, with short-term mortality still reaching 40-50%, relatively …

Aims Few studies have reported data on the optimal timing of left ventricular (LV) unloading
during venoarterial extracorporeal membrane oxygenation (VA‐ECMO) for cardiac arrest or …

OBJECTIVES: Refractory postcardiotomy cardiogenic shock complicating cardiac surgery
yields nearly 100% mortality when untreated. Use of venoarterial extracorporeal membrane …

Extracorporeal membrane oxygenation (ECMO) provides advanced cardiopulmonary life
support for patients in cardiac and/or respiratory failure. Echocardiography provides …

Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient
systemic perfusion and end-organ dysfunction. Though significant advances have been …

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used to sustain
circulatory and respiratory support in patients with severe cardiogenic shock or refractory …

Background Mortality for patients on veno-arterial extracorporeal membrane oxygenation
(VA-ECMO) for cardiogenic shock (CS) complicating acute myocardial infarction (AMI) …

This review describes the intricate physiological interactions involved in the application of
extracorporeal therapy, with specific focus on cardiopulmonary relationships. Extracorporeal …

Although mechanical circulatory support (MCS) has been used to support patients with
cardiogenic shock (CS) for many years, recent advances in device technology, together with …